/stocks — the workspaceLOADING
All ALMRSEC filings, by type → · Earnings date & implied move · Search inside filings
Alamar Biosciences, Inc. (ALMR) is a laboratory analytical instruments company. 2 insider Form 4 filings in the last 90 days. Fundamentals from SEC filings; prices are end-of-day.
What’s behind ALMR’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
A plain-English read on ALMR plus an auto-SWOT — built from ALMR's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate ALMR using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Has ALMR been issuing shares? Offering history →
No lawmaker has disclosed a trade in ALMR under the STOCK Act.
No tracked institution reported a position in ALMR in the latest 13F round.
Every registered fund files its complete portfolio with the SEC. These weights come from those filings, so each one carries the period it describes. Holdings are quarterly and filed in arrears — the figures below are as of 2026-06-30, not today.
| Fund | Weight | As of |
|---|---|---|
| IWM iShares Russell 2000 ETF | 0.01% | 2026-06-30 |
| VTI Vanguard Total Stock Market ETF | <0.01% | 2026-06-30 |
Drawn from 39 large US equity funds we scan, not every fund in existence, so a missing fund means we do not scan it rather than that it holds none. Holdings are joined to tickers by issuer name, which does not resolve every position; what that misses is published.
Head office: Fremont, California, United States · the company’s charter and its head office are in different states.
Source: the cover page of Alamar Biosciences, Inc.’s 10-Q filed 2026-08-11, on EDGAR. Incorporation is where the company’s charter was filed. It is not where the business operates or earns, which no filing cover states. How this works
| Naclerio NicholasDirector | BUY | $4.0M | view → |
| Illumina Innovation Fund II GP, L.L.C.10% owner | BUY | $4.0M | view → |
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.
Projected from ALMR's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentALMR files or announces.
| Reported | Close-to-close |
|---|---|
| 2026-08-10 | +28.5% |
| 2026-05-08 | +0.9% |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.